PerCP/Cyanine5.5 anti-human CD203c (E-NPP3) [NP4D6]

The University of Virginia awarded contract A207_PO-0485145 to BioLegend Inc. on September 26, 2026, for the procurement of specialized immunological reagents. The prime contractor will deliver one unit of PerCP/Cyanine5.5 anti-human CD203c (E-NPP3) [NP4D6], a fluorescently-labeled monoclonal antibody targeting the ecto-nucleotide pyrophosphatase/phosphodiesterase-3 (E-NPP3) protein marker. The reagent is to be delivered to Martha Joy Macdonald Spano at the University of Virginia in Virginia.

The contract value totals two hundred eighty-seven dollars ($287), representing a single purchase order transaction. The contract award details do not specify a formal contract period of performance beyond the award date; however, the transaction nature and delivery specification indicate this represents a one-time procurement of laboratory research materials. As a Virginia state institution, the University of Virginia serves as both the contracting organization and place of performance for this biological reagent acquisition.